Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001375:Azaguanine / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D005650:Fumarates / Q000378:metabolism; D005965:Glucuronates / Q000378:metabolism; D007501:Iron / Q000378:metabolism*; D015122:Mercaptopurine / Q000494:pharmacology*; D051379:Mice; D013852:Thiotepa
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D005650:Fumarates; D005965:Glucuronates; D013852:Thiotepa; D007501:Iron; D015122:Mercaptopurine; D001375:Azaguanine